Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to $171000.0.

  • Lifecore Biomedical, Inc. \De\'s Other Non Operating Income rose 11551.72% to $171000.0 in Q2 2025 from the same period last year, while for May 2025 it was -$3000.0, marking a year-over-year increase of 9990.17%. This contributed to the annual value of -$3000.0 for FY2025, which is 9990.17% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Other Non Operating Income of $171000.0 as of Q2 2025, which was up 11551.72% from $333000.0 recorded in Q1 2025.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Other Non Operating Income peaked at $333000.0 during Q1 2025, and registered a low of -$23.4 million during Q2 2023.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Other Non Operating Income had a median value of -$109500.0 in 2021 and averaged -$1.4 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 35522.39% in 2021, then plummeted by 1993983.05% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Other Non Operating Income (Quarter) stood at $330000.0 in 2021, then plummeted by 171.82% to -$237000.0 in 2022, then plummeted by 308.02% to -$967000.0 in 2023, then skyrocketed by 68.56% to -$304000.0 in 2024, then skyrocketed by 156.25% to $171000.0 in 2025.
  • Its last three reported values are $171000.0 in Q2 2025, $333000.0 for Q1 2025, and -$304000.0 during Q4 2024.